Camille Ann Stich, | |
14301 Ewing Ave S, Burnsville, MN 55306-4885 | |
(952) 746-5350 | |
Not Available |
Full Name | Camille Ann Stich |
---|---|
Gender | Female |
Speciality | Clinic/center - Developmental Disabilities |
Location | 14301 Ewing Ave S, Burnsville, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003555657 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225XM0800X | Occupational Therapist - Mental Health | (* (Not Available)) | Secondary |
261QD1600X | Clinic/center - Developmental Disabilities | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Camille Ann Stich, 14301 Ewing Ave S, Burnsville, MN 55306-4885 Ph: (952) 746-5350 | Camille Ann Stich, 14301 Ewing Ave S, Burnsville, MN 55306-4885 Ph: (952) 746-5350 |
News Archive
A program established by investigators from the Ragon Institute of Massachusetts General Hospital, MIT and Harvard is addressing the persistently elevated risk of HIV infection among young women in South Africa from two angles - first, investigating biological factors that modulate infection risk along with the early immunologic events following viral exposure, and second, alleviating the socioeconomic factors that limit opportunities for young women, the group at greatest risk of infection in the region of the world hardest hit by the HIV epidemic.
A new survey has found that African-Americans are more likely than whites to hold mistaken and fatalistic beliefs about lung cancer, as well as being more reluctant to consult a doctor about possible symptoms of the disease, according to researchers from Dana-Farber Cancer Institute and their collaborators.
Nearly one in three low-income people who enrolled in Michigan's expanded Medicaid program discovered they had a chronic illness that had never been diagnosed before, according to a new study.
Cardiovascular physiology researcher Victoria Claydon's latest study, published in the Journal of Neurotrauma, focuses on the results of her multi-national study, which surveyed almost 300 participants with spinal cord injuries at or above the mid-thoracic level (middle of the chest ).
Taking a vitamin A derivative called isotretinoin did not reduce the risk of second primary tumors or improve survival in patients with stage I or II head and neck squamous cell cancers (HNSCC), according to a study in the Journal of the National Cancer Institute.
› Verified 9 days ago